A Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of RO7062931in Healthy Volunteers and Subjects With Chronic Hepatitis B
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Chronic Hepatitis B
Related studies linked through entity extraction aliases.
Study of the Relative Oral Bioavailability of AL-3778 Tablets and Drug Interaction With Entecavir or Tenofovir Disoproxil Fumarate in Healthy Volunteers
- Status
- TERMINATED
- Phase
- PHASE1
Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers
- Status
- UNKNOWN
- Phase
- PHASE3
Study to Evaluate Efficacy and Safety of Switching From TDF to TAF in Adults With Chronic Hepatitis B Who Are Virologically Suppressed
- Status
- COMPLETED
- Phase
- PHASE3
Peginterferon Alfa-2b Treatment in HBeAg(+) Chronic Hepatitis b Patients Based on Interferon Gene Mutation and Receptor Detection
- Status
- UNKNOWN
- Phase
- PHASE4
The Safety and Dose-range Study of Metacavir Enteric-coated Capsules in Patients With Chronic Hepatitis B
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
HBsAg Loss/Seroconversion in Low Replicative Chronic Hepatitis B Virus(HBV) Infection Patients
- Status
- UNKNOWN
- Phase
- PHASE4
A Study in Healthy Volunteers and Patients With Chronic Hepatitis B
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Interruption on the Mother-to-child Transmission of Hepatitis B Virus （HBV MTCT）in Newborns at High Risk
- Status
- UNKNOWN
- Phase
- N/A
Effect of Polyherbal Formulation in Chronic Inactive Carriers of Hepatitis B Virus
- Status
- UNKNOWN
- Phase
- NA
A Study to Evaluate Addition of Peginterferon Alfa-2a to Chronic Hepatitis B (CHB) Patients Treated With NAs
- Status
- UNKNOWN
- Phase
- PHASE4
The Optimizing Treatment of Peginterferon (PEG IFN) Alpha in Chronic Hepatitis B Virus Patients With Low Level HBsAg
- Status
- UNKNOWN
- Phase
- PHASE4
Immune Function Status and the Prevalence of Hepatitis in Postpartum Pregnant Women With CHB Infection
- Status
- UNKNOWN
- Phase
- N/A
Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis b
- Status
- RECRUITING
- Phase
- N/A
Myrcludex B vs Entecavir in Patients With HBeAg Negative Chronic Hepatitis B
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease
- Status
- RECRUITING
- Phase
- N/A
Efficacy and Safety of Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF)-Containing Regimens in Participants With Chronic Hepatitis B Virus (HBV) Infection and Stage 2 or Greater Chronic Kidney Disease Who Have Received a Liver Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Second Stage:Open-label Study of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B
- Status
- COMPLETED
- Phase
- PHASE2
The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg
- Status
- UNKNOWN
- Phase
- PHASE4